CUSIP: 89853L104
Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
19,181,967
-
Share change
-
-3,858,945
-
Total reported value
-
$9,901,613
-
Put/Call ratio
-
78%
-
Price per share
-
$0.52
-
Number of holders
-
72
-
Value change
-
-$2,401,321
-
Number of buys
-
23
-
Number of sells
-
29
Quarterly Holders Quick Answers
What is CUSIP 89853L104?
CUSIP 89853L104 identifies TTOO - T2 BIOSYSTEMS INC - COM in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
-
Newer quarter:
Q1 2022
-
Previous quarter:
Q3 2021
Recent filing periods for CUSIP 89853L104:
Institutional Holders of T2 BIOSYSTEMS INC - COM (TTOO) as of Q4 2021
As of 31 Dec 2021,
T2 BIOSYSTEMS INC - COM (TTOO) was held by
72 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
19,181,967 shares.
The largest 10 holders included
VANGUARD GROUP INC, BlackRock Inc., GOLDMAN SACHS GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, MILLENNIUM MANAGEMENT LLC, GAGNON SECURITIES LLC, STATE STREET CORP, SUSQUEHANNA INTERNATIONAL GROUP, LLP, CITADEL ADVISORS LLC, and BRIDGEWAY CAPITAL MANAGEMENT, LLC.
This page lists
72
institutional shareholders reporting positions in this security
for the Q4 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.